Biopharma Deal Value, Volume Tumbled Substantially During First Half

 
• By Joseph Haas
  
Straight_Road
After a decline in deal-making during the first half, PwC expects higher activity during latter 2020
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business